TrialAdvances in therapy2020

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.

Hoda Taheri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.